Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jul;2(3):480-3.
doi: 10.1602/neurorx.2.3.480.

Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias

Veronica F Colomer Gould  1
Affiliations
Review

Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias

Veronica F Colomer Gould. NeuroRx. 2005 Jul.

Abstract

Machado-Joseph disease (MJD), also called spinocerebellar ataxia type 3, is caused by mutant ataxin-3 with a polyglutamine expansion. Although there is no treatment available at present to cure or delay the onset of MJD, mouse models have been generated to facilitate the development of a therapy. In this review, the published reports on mouse models of MJD and other polyglutamine spinocerebellar ataxias are compared. Based on these studies, the following approaches will be discussed as candidate treatments for MJD: 1) interfering with the formation of the mutant ataxin-3 cleavage fragment and possibly aggregate or inclusions, 2) reducing the disease protein nuclear localization, and 3) decreasing mutant ataxin-3 expression in neurons.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Sudarsky L, Coutinho P. Machado-Joseph disease. Clin Neurosci 3: 17–22, 1995. - PubMed
    1. Zoghbi HY, Orr H T. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23: 217–247, 2000. - PubMed
    1. Nakamura K, Jeong S Y, Uchihara T, Anno M, Nagashima K, Nagashima T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 10: 1441–1448, 2001. - PubMed
    1. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 8: 221–228, 1994. - PubMed
    1. Takiyama Y, Sakoe K, Nakano I, Nishizawa M. Machado-Joseph disease: cerebellar ataxia and autonomic dysfunction in a patient with the shortest known expanded allele (56 CAG repeat units) of the MJD1 gene. Neurology 49: 604–606, 1997. - PubMed